252 related articles for article (PubMed ID: 26283785)
1. Matrix Metalloproteinase (MMP) Proteolysis of the Extracellular Loop of Voltage-gated Sodium Channels and Potential Alterations in Pain Signaling.
Remacle AG; Kumar S; Motamedchaboki K; Cieplak P; Hullugundi S; Dolkas J; Shubayev VI; Strongin AY
J Biol Chem; 2015 Sep; 290(38):22939-44. PubMed ID: 26283785
[TBL] [Abstract][Full Text] [Related]
2. [Pain and analgesia : Mutations of voltage-gated sodium channels].
Eberhardt MJ; Leffler A
Schmerz; 2017 Feb; 31(1):14-22. PubMed ID: 27402262
[TBL] [Abstract][Full Text] [Related]
3. Novel SCN9A mutations underlying extreme pain phenotypes: unexpected electrophysiological and clinical phenotype correlations.
Emery EC; Habib AM; Cox JJ; Nicholas AK; Gribble FM; Woods CG; Reimann F
J Neurosci; 2015 May; 35(20):7674-81. PubMed ID: 25995458
[TBL] [Abstract][Full Text] [Related]
4. Sodium channel NaV1.9 mutations associated with insensitivity to pain dampen neuronal excitability.
Huang J; Vanoye CG; Cutts A; Goldberg YP; Dib-Hajj SD; Cohen CJ; Waxman SG; George AL
J Clin Invest; 2017 Jun; 127(7):2805-2814. PubMed ID: 28530638
[TBL] [Abstract][Full Text] [Related]
5. Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations.
Cox JJ; Sheynin J; Shorer Z; Reimann F; Nicholas AK; Zubovic L; Baralle M; Wraige E; Manor E; Levy J; Woods CG; Parvari R
Hum Mutat; 2010 Sep; 31(9):E1670-86. PubMed ID: 20635406
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for severe pain caused by mutations in the S4-S5 linkers of voltage-gated sodium channel Na
Wisedchaisri G; Gamal El-Din TM; Zheng N; Catterall WA
Proc Natl Acad Sci U S A; 2023 Apr; 120(14):e2219624120. PubMed ID: 36996107
[TBL] [Abstract][Full Text] [Related]
7. Gain-of-function mutation of a voltage-gated sodium channel Na
Tanaka BS; Nguyen PT; Zhou EY; Yang Y; Yarov-Yarovoy V; Dib-Hajj SD; Waxman SG
J Biol Chem; 2017 Jun; 292(22):9262-9272. PubMed ID: 28381558
[TBL] [Abstract][Full Text] [Related]
8. Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors.
Shields SD; Deng L; Reese RM; Dourado M; Tao J; Foreman O; Chang JH; Hackos DH
J Neurosci; 2018 Nov; 38(47):10180-10201. PubMed ID: 30301756
[TBL] [Abstract][Full Text] [Related]
9. Backbone resonance assignments of complexes of apo human calmodulin bound to IQ motif peptides of voltage-dependent sodium channels Na
Isbell HM; Kilpatrick AM; Lin Z; Mahling R; Shea MA
Biomol NMR Assign; 2018 Oct; 12(2):283-289. PubMed ID: 29728980
[TBL] [Abstract][Full Text] [Related]
10. Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders.
Drenth JP; Waxman SG
J Clin Invest; 2007 Dec; 117(12):3603-9. PubMed ID: 18060017
[TBL] [Abstract][Full Text] [Related]
11. Variable patterns of mutation density among NaV1.1, NaV1.2 and NaV1.6 point to channel-specific functional differences associated with childhood epilepsy.
Encinas AC; Watkins JC; Longoria IA; Johnson JP; Hammer MF
PLoS One; 2020; 15(8):e0238121. PubMed ID: 32845893
[TBL] [Abstract][Full Text] [Related]
12. Defining the Functional Role of Na
McDermott LA; Weir GA; Themistocleous AC; Segerdahl AR; Blesneac I; Baskozos G; Clark AJ; Millar V; Peck LJ; Ebner D; Tracey I; Serra J; Bennett DL
Neuron; 2019 Mar; 101(5):905-919.e8. PubMed ID: 30795902
[TBL] [Abstract][Full Text] [Related]
13. Voltage-gated sodium channels and pain-related disorders.
Kanellopoulos AH; Matsuyama A
Clin Sci (Lond); 2016 Dec; 130(24):2257-2265. PubMed ID: 27815510
[TBL] [Abstract][Full Text] [Related]
14. Diversity of composition and function of sodium channels in peripheral sensory neurons.
Dib-Hajj SD; Waxman SG
Pain; 2015 Dec; 156(12):2406-7. PubMed ID: 26580678
[No Abstract] [Full Text] [Related]
15. Calmodulin and Ca(2+) control of voltage gated Na(+) channels.
Gabelli SB; Yoder JB; Tomaselli GF; Amzel LM
Channels (Austin); 2016; 10(1):45-54. PubMed ID: 26218606
[TBL] [Abstract][Full Text] [Related]
16. A nonsense mutation in the SCN9A gene in congenital insensitivity to pain.
Kurban M; Wajid M; Shimomura Y; Christiano AM
Dermatology; 2010; 221(2):179-83. PubMed ID: 20628234
[TBL] [Abstract][Full Text] [Related]
17. Novel
Sun J; Li L; Yang L; Duan G; Ma T; Li N; Liu Y; Yao J; Liu JY; Zhang X
Mol Pain; 2020; 16():1744806920923881. PubMed ID: 32420800
[TBL] [Abstract][Full Text] [Related]
18. The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy.
Han C; Yang Y; de Greef BT; Hoeijmakers JG; Gerrits MM; Verhamme C; Qu J; Lauria G; Merkies IS; Faber CG; Dib-Hajj SD; Waxman SG
Neuromolecular Med; 2015 Jun; 17(2):158-69. PubMed ID: 25791876
[TBL] [Abstract][Full Text] [Related]
19. Altered sodium channel gating as molecular basis for pain: contribution of activation, inactivation, and resurgent currents.
Lampert A; Eberhardt M; Waxman SG
Handb Exp Pharmacol; 2014; 221():91-110. PubMed ID: 24737233
[TBL] [Abstract][Full Text] [Related]
20. Natural mutations change the affinity of μ-theraphotoxin-Hhn2a to voltage-gated sodium channels.
Zhang F; Liu Y; Zhang C; Li J; Yang Z; Gong X; Gan Y; Chen P; Liu Z; Liang S
Toxicon; 2015 Jan; 93():24-30. PubMed ID: 25447770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
